Literature DB >> 29095463

Analogues of Pseudomonas aeruginosa signalling molecules to tackle infections.

Eoin Ó Muimhneacháin1, F Jerry Reen, Fergal O'Gara, Gerard P McGlacken.   

Abstract

The emergence of antibiotic resistance coupled with the lack of investment by pharmaceutical companies necessitates a new look at how we tackle bacterial infections. An intriguing tactic is the interruption of bacterial communication systems. This non-biocidal approach would circumvent the evolutionary pressure on bacteria to mutate and develop resistance. In many pathogenic microorganisms, communication systems, collectively termed quorum sensing (QS), have been observed to control a number of bacterial behaviours including expression of virulence factors and the development of biofilms. QS signalling molecules and their biomimetics, therefore, represent a rational target for the disruption of cooperative behaviour and thus the development of novel antimicrobial strategies. Herein we review recent developments towards the interference of Pseudomonas aeruginosa QS using signalling molecules and their mimetics.

Entities:  

Mesh:

Year:  2018        PMID: 29095463     DOI: 10.1039/c7ob02395b

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  9 in total

1.  A comparative study of non-native N-acyl l-homoserine lactone analogs in two Pseudomonas aeruginosa quorum sensing receptors that share a common native ligand yet inversely regulate virulence.

Authors:  Michelle E Boursier; Daniel E Manson; Joshua B Combs; Helen E Blackwell
Journal:  Bioorg Med Chem       Date:  2018-05-14       Impact factor: 3.641

Review 2.  Virulence attenuating combination therapy: a potential multi-target synergy approach to treat Pseudomonas aeruginosa infections in cystic fibrosis patients.

Authors:  Elana Shaw; William M Wuest
Journal:  RSC Med Chem       Date:  2020-02-19

Review 3.  Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections.

Authors:  Yu-Xuan Ma; Chen-Yu Wang; Yuan-Yuan Li; Jing Li; Qian-Qian Wan; Ji-Hua Chen; Franklin R Tay; Li-Na Niu
Journal:  Adv Sci (Weinh)       Date:  2019-12-05       Impact factor: 16.806

4.  Molecular Modifications of the Pseudomonas Quinolone Signal in the Intermicrobial Competition with Aspergillus.

Authors:  Hasan Nazik; Gabriele Sass; Paul Williams; Eric Déziel; David A Stevens
Journal:  J Fungi (Basel)       Date:  2021-04-28

5.  Synthesis and biological evaluation of 1,2-disubsubstituted 4-quinolone analogues of Pseudonocardia sp. natural products.

Authors:  Stephen M Geddis; Teodora Coroama; Suzanne Forrest; James T Hodgkinson; Martin Welch; David R Spring
Journal:  Beilstein J Org Chem       Date:  2018-10-19       Impact factor: 2.883

6.  Quinolones Modulate Ghrelin Receptor Signaling: Potential for a Novel Small Molecule Scaffold in the Treatment of Cachexia.

Authors:  Cristina Torres-Fuentes; Elena Pastor-Cavada; Rafael Cano; Dalia Kandil; Rachel Shanahan; Rocio Juan; Hamdy Shaban; Gerard P McGlacken; Harriët Schellekens
Journal:  Int J Mol Sci       Date:  2018-05-30       Impact factor: 5.923

7.  Targeted specific inhibition of bacterial and Candida species by mesoporous Ag/Sn-SnO2 composite nanoparticles: in silico and in vitro investigation.

Authors:  Monica Pandey; Kirti Wasnik; Shubhra Gupta; Monika Singh; Sukanya Patra; Premshankar Gupta; Divya Pareek; Somedutta Maity; Ragini Tilak; Pradip Paik
Journal:  RSC Adv       Date:  2022-01-05       Impact factor: 3.361

Review 8.  Pathogenetic Impact of Bacterial-Fungal Interactions.

Authors:  Filomena Nogueira; Shirin Sharghi; Karl Kuchler; Thomas Lion
Journal:  Microorganisms       Date:  2019-10-16

Review 9.  Quorum Sensing Inhibitors to Quench P. aeruginosa Pathogenicity.

Authors:  Marine Duplantier; Elodie Lohou; Pascal Sonnet
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.